• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Recent Advances in the Study of 2-Bromo-3-(1-naphthyl)-1-propene (CAS: 116545-04-1) in Chemical Biology and Pharmaceutical Research

The compound 2-Bromo-3-(1-naphthyl)-1-propene (CAS: 116545-04-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery. This brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential. The compound's naphthyl and bromo-functionalized propene structure makes it a versatile intermediate for the development of novel bioactive molecules.

Recent studies have explored the synthetic pathways for 2-Bromo-3-(1-naphthyl)-1-propene, highlighting its role as a key intermediate in the synthesis of more complex molecules. Researchers have optimized reaction conditions to improve yield and purity, which is critical for its application in high-throughput screening and medicinal chemistry. The compound's reactivity, particularly its ability to undergo cross-coupling reactions, has been leveraged to create libraries of derivatives with potential pharmacological activities.

In terms of biological activity, preliminary in vitro studies have demonstrated that 2-Bromo-3-(1-naphthyl)-1-propene exhibits moderate inhibitory effects on certain enzymatic targets, including kinases and proteases. These findings suggest its potential as a scaffold for the development of enzyme inhibitors. Moreover, its interaction with cellular membranes and potential to modulate signal transduction pathways are currently under investigation, with promising results in early-stage cell-based assays.

One of the most exciting developments is the exploration of 2-Bromo-3-(1-naphthyl)-1-propene in anticancer research. Recent publications have reported its ability to induce apoptosis in specific cancer cell lines, possibly through the disruption of mitochondrial function. These findings are supported by molecular docking studies, which predict strong binding affinities to proteins involved in cell cycle regulation. However, further in vivo studies are required to validate these observations and assess the compound's safety profile.

In conclusion, 2-Bromo-3-(1-naphthyl)-1-propene (CAS: 116545-04-1) represents a promising candidate for further investigation in drug discovery and chemical biology. Its synthetic accessibility, combined with its diverse biological activities, positions it as a valuable tool for researchers. Future studies should focus on elucidating its mechanism of action, optimizing its pharmacokinetic properties, and exploring its potential in combination therapies. The compound's progress will be closely monitored by the scientific community, as it may pave the way for novel therapeutic interventions.

• 60468-22-6((2-bromoprop-2-en-1-yl)benzene)
• 842140-43-6(2-Bromo-3-(4-n-propylphenyl)-1-propene)
• 731772-14-8(2-Bromo-3-(2-methylphenyl)-1-propene)
• 842140-37-8(2-Bromo-3-(3,5-dimethylphenyl)-1-propene)
• 842140-27-6(2-Bromo-3-(4-tert-butylphenyl)-1-propene)
• 1263365-87-2(2-Bromo-3-(2-ethylphenyl)-1-propene)
• 731772-18-2(2-Bromo-3-(3-methylphenyl)-1-propene)
• 731772-21-7(2-Bromo-3-(4-methylphenyl)-1-propene)
• 842124-28-1(2-Bromo-3-(4-n-butylphenyl)-1-propene)
• 91391-61-6(2-Bromo-3-(4-bromophenyl)-1-propene)